The FDA has acknowledged this reality on the label itself: weight care requires ongoing therapy , and GLP-1 drugs are approved for chronic weight management only as an adjunct to diet and exercise they are not magic bullets that cure obesity after a few doses
When taken according to recommended dosage, most healthy adults tolerate glutathione supplements well
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.N Engl J Med.2019Aug29;381(9):841 51
This is why Walshs approach emphasizes balancing methylationnot with folates, which can worsen symptoms in undermethylated individualsbut with nutrients that rebuild the methyl cycle naturally
KEYWORDS: Advertising, direct-to-consumer, compounded, GLP-1, obesity, semaglutide, tirzepatide, weight loss Background To date, the Food and Drug Administration (FDA) has approved three glucagon-like peptide-1 (GLP-1) receptor agonists as pharmacologic treatments for chronic weight management (Chen et al., 2023)
